Abstract | AIMS: METHODS: Tissues from 33 cases of Hodgkin's disease were studied for the presence of EBV DNA by polymerase chain reaction (PCR) and DNA in situ hybridisation (DISH), for the presence of EBER-1 and EBER-2 EBV RNA by RNA in situ hybridisation (RISH); and for the presence of LMP, bcl-2, and c-myc proteins by immunohistochemical staining. RESULTS: A substantial number of Reed-Sternberg cells expressed bcl-2 in 20 of 29 (69%) and c-myc in 30 of 32 (94%) Hodgkin's disease samples. In 18 of the 25 (72%) cases Reed-Sternberg cells expressed both oncogene products. Of these 18 cases, 10 (56%) were EBV-PCR positive; eight (44%) were EBV-PCR negative. CONCLUSIONS: Reed-Sternberg cells in Hodgkin's disease frequently express both bcl-2 and c-myc oncogene products, suggesting that these oncogenes may act in concert in the pathogenesis of the disease. Moreover, the expression of c-myc and bcl-2 proteins in Reed-Sternberg cells is independent of EBV and LMP status.
|
Authors | N M Jiwa, P Kanavaros, P van der Valk, J M Walboomers, A Horstman, W Vos, H Mullink, C J Meijer |
Journal | Journal of clinical pathology
(J Clin Pathol)
Vol. 46
Issue 3
Pg. 211-7
(Mar 1993)
ISSN: 0021-9746 [Print] England |
PMID | 8385158
(Publication Type: Journal Article)
|
Chemical References |
- Antigens, Viral
- DNA, Viral
- EBV-associated membrane antigen, Epstein-Barr virus
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins c-myc
- Viral Envelope Proteins
- Viral Matrix Proteins
|
Topics |
- Antigens, Viral
(analysis)
- Base Sequence
- DNA, Viral
(analysis)
- Gene Expression Regulation, Neoplastic
- Herpesvirus 4, Human
(genetics, isolation & purification)
- Hodgkin Disease
(metabolism, microbiology)
- Humans
- Immunohistochemistry
- In Situ Hybridization
- Molecular Sequence Data
- Polymerase Chain Reaction
- Proto-Oncogene Proteins
(analysis, genetics)
- Proto-Oncogene Proteins c-myc
(analysis, genetics)
- Reed-Sternberg Cells
(chemistry, microbiology)
- Viral Envelope Proteins
(analysis)
- Viral Matrix Proteins
(analysis)
|